NSE: ACI· ChemicalsNot in Aug top-30Small cap
Archean Chemical Industries
Bromine cost-curve leader
- Last close
- ₹490.60
- 29 Sept 2026 · reference
- 1D · 1M
- +1.6% · +1.3%
- price-only
- Weight
- 0.6%
- 31 Jul 2026 · Aug rank —
- Thesis review
- 8 Sep 2026
- Why We Own, p66
Where the price sits
52-week range, house target and street targets
52w low ₹45552w high ₹693
- Reference close₹491
Range from reference closes; street targets from the PDFs on file (Research & documents). Internal target is never shown to prospects.
Investment case and valuation
Approved model, 8 Sep 2026 review
₹499
Price (2026-09-07)
44.2x / 34.6x
FY27E / FY28E P/E (Buoyant sheet)
7.9%
FY27E ROE (Buoyant sheet)
63.6x
Trailing P/E
3.2x
Price / book
n.a.
EPS CAGR FY26–28E
63.6x TTM PE reflects trough earnings (FY26 PAT Rs 105 cr vs Rs 319 cr in FY24); P/B 3.2x (499/157). Stock -27% over 1 year and 3-yr profit CAGR -35%; Buoyant 34.6x FY28e vs ICICI Sec 16x FY28E EBITDA. EV/EBITDA n.m.; dividend yield 0.5%.
- Model date
- 8 Sep 2026 (prices 7–8 Sep 2026)
- Horizon
- 12 months (bank pages: Sep-2027 roll-forward)
- Audience
- Internal — the book's guardrail: do not quote a target to a client; quote the thesis and the risk
- Reviewer · version
- Investment Committee framework · v1 (book)
Current vs history
Trailing multiples, FY-end
| Ratio | FY16 | FY17 | FY18 | FY19 | FY20 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. | 20.9x | 25.9x | 39.2x | 67.8x |
| Price to Book | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. | 5.6x | 4.9x | 3.4x | 3.8x |
Tijori FY-end multiples on reported earnings/book; compatible definitions across years, but not the same basis as Buoyant's forward P/E on internal EPS.
UnavailableScenario lab disabled. Needs an approved forward EPS and forward P/E for Archean Chemical Industries plus a reference price. Missing inputs are not substituted.